肝片形吸虫防御分子保护小鼠抵抗盲肠结扎穿孔诱导的多微生物脓毒症
脓毒症由感染引起的宿主免疫反应失调所致,每年约1100万人死亡。本研究用盲肠结扎穿孔模型复制小鼠脓毒症,组织学和生物标志物多重分析显示模型在24小时内启动大规模炎症反应,48-72小时出现急性器官损伤证据。多种典型促炎细胞因子/趋化因子全身升高,其中IL-10、eotaxin、MIP-1α、MIP-1β、MCP-1和RANTES在动物达到人道终点前明显升高。给予小鼠10 μg源自肝片形吸虫(F. hepatica)免疫调节分子的合成68氨基酸肽(肝片形吸虫防御分子),强烈抑制全身炎症谱、保护小鼠抵抗急性肾损伤,并改善操作后48-72小时生存。作者认为该抗炎寄生虫来源肽有潜力作为脓毒症的生物治疗。
要点
- 盲肠结扎穿孔小鼠模型在24小时内启动大规模炎症反应,48-72小时出现急性器官损伤证据。
- IL-10、eotaxin、MIP-1α、MIP-1β、MCP-1和RANTES在动物达到人道终点前明显升高。
- 给予10 μg合成68氨基酸肝片形吸虫防御分子肽可强烈抑制全身炎症谱。
- 该肽保护小鼠抵抗急性肾损伤,并改善操作后48-72小时生存。
- 作者认为该抗炎寄生虫来源肽有潜力作为脓毒症的生物治疗。
适用人群与场景
- 盲肠结扎穿孔诱导多微生物脓毒症的小鼠
处置流程与药物剂量
- 给予小鼠10 μg源自肝片形吸虫的合成68氨基酸防御分子肽治疗。
研究设计与关键结果
- 盲肠结扎穿孔模型在24小时内启动大规模炎症反应,48-72小时出现急性器官损伤证据。
- 多种典型促炎细胞因子/趋化因子全身升高,IL-10、eotaxin、MIP-1α、MIP-1β、MCP-1和RANTES在动物达到人道终点前明显升高。
- 10 μg肝片形吸虫防御分子肽强烈抑制全身炎症谱,保护小鼠抵抗急性肾损伤,并改善操作后48-72小时生存。
证据类型、等级与局限
- 证据类型:动物实验(小鼠盲肠结扎穿孔模型)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为抗炎寄生虫来源的肝片形吸虫防御分子肽有潜力作为脓毒症的生物治疗。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Sepsis results from a dysregulated host immune response to infection and is responsible for ~11 million deaths each year. In the laboratory, many aspects of sepsis can be replicated using a cecal ligation and puncture model, which is considered the most clinically relevant rodent model of sepsis. In the present study, histological and biomarker multiplex analyses revealed that the cecal ligation and puncture model initiated a large-scale inflammatory response in mice by 24 h, with evidence of acute organ damage by 48-72 h. While many typical proinflammatory cytokine/chemokines were systemically elevated, a specific array including IL-10, eotaxin, MIP-1α, MIP-1β, MCP-1, and RANTES noticeably increased just prior to animals reaching the humane endpoint. Treatment of mice with 10 μg of a synthetic 68-amino acid peptide derived from an immunomodulatory molecule secreted by a parasitic worm of humans and livestock, F. hepatica , termed F. hepatica helminth defense molecule, potently suppressed the systemic inflammatory profile, protected mice against acute kidney injury, and improved survival between 48 and 72 h after procedure. These results suggest that the anti-inflammatory parasite-derived F. hepatica helminth defense molecule peptide has potential as a biotherapeutic treatment for sepsis.
参考来源
- Fazekas B, Hamon S, De Marco Verissimo C, et al. PROTECTION OF MICE AGAINST CECAL LIGATION AND PUNCTURE-INDUCED POLYMICROBIAL SEPSIS BY A FASCIOLA HEPATICA HELMINTH DEFENSE MOLECULE. Shock. 2024. PMID: 39455069. doi:10.1097/SHK.0000000000002489
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。